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Protein Topology of Presenilin 1
Andrew Doan,1,4,7 Gopal Thinakaran,2,4,7 PS and the mechanisms by which FAD-linked PS vari-
ants cause AD remain to be elucidated.David R. Borchelt,2,4 Hilda H. Slunt,4
Tamara Ratovitsky,4 Marcia Podlisny,5 PS1 is a 467 amino acid peptide predicted to contain
between seven (Sherrington et al., 1995) and nine (SluntDennis J. Selkoe,5 Mary Seeger,6
Samuel E. Gandy,6 Donald L. Price,1,2,3,4 et al., 1995) transmembrane (TM) helices and a hydro-
philic acidic “loop” region encompassing amino acidsand Sangram S. Sisodia,1,2,4
1Department of Neuroscience 263–407. We recently documented that PS1 is subject to
endoproteolytic cleavage between amino acids 260–3202Department of Pathology
3Department of Neurology to generate z27–28 kDa N-terminal and z17–18 kDa
derivatives (Thinakaran et al., 1996a). Although earlier4The Neuropathology Laboratory
The Johns Hopkins University immunocytochemical studies in transfected cells docu-
mented that PS1 is localized to the endoplasmic reticu-School of Medicine
Baltimore, Maryland 21205 lum (ER) and to a lesser extent, the Golgi compartment
(Kovacs et al., 1996), the topological orientation of the5Center for Neurologic Diseases
Brigham and Women’s Hospital PS1 loop, N-terminal, and C-terminal domains have not
been established. We sought to determine the topologyBoston, Massachusetts 02115
6Department of Neurology and Neuroscience of PS1 in order to identify domains that may mediate
functional activities of the polypeptide. In this regard, aCornell University Medical College
New York, New York 10021 PS homolog in Caenorhabditis elegans, termed SEL-12,
facilitates intracellular signaling pathways mediated by
LIN-12/Notch activation (Levitan and Greenwald, 1995).
To establish the topology of PS1, we utilized two novelSummary
strategies: first, we tested whetherputative “TM helices”
are sufficient to export a protease-sensitive substrateMutations in a gene encoding a multitransmembrane
across a lipid bilayer; and second, we selectively perme-protein, termed presenilin 1 (PS1), are causative in the
abilized theplasma membrane of cultured cells express-majority of early-onset cases of AD. To determine the
ing huPS1 or PS1DE9 and examined whether the N-ter-topology of PS1, we utilized two strategies: first, we
minus, loop, and C-terminus were accessible to specifictested whether putative transmembranes are suffi-
antibodies raised against each domain. In this report,cient to export a protease-sensitive substrate across
we provide compelling evidence for the cytoplasmica lipid bilayer; and second, we examined the binding
localization of the loop, N-terminal, and C-terminal do-of antibodies to specific PS1 epitopes in cultured cells
mains of PS1. Taken together with our demonstrationselectively permeabilized with the pore-forming toxin,
that the topology of thePS1DE9 variant appears indistin-streptolysin-O. We document that the “loop,” N-termi-
guishable from wild-type PS1, we offer several topologynal, and C-terminal domains of PS1 are oriented to-
models for PS1. Identification of cytosolic moleculesward the cytoplasm.
that interact with PS1 intracellular domains will greatly
facilitate future efforts aimed at clarifying the normal
Introduction biology of PS1.
Alzheimer’s disease (AD), a progressive neurodegenera-
Resultstive disorder, is characterized by thepresence of numer-
ous senile plaques and neurofibrillary tangles in the ce-
Determination of PS1 N-Terminus Topologyrebral cortex and hippocampus of affected individuals
Using PS1–APP Chimeric Proteins(Wisniewski and Terry, 1973). Early-onset AD is highly
In earlier efforts, we established that the APP “Swedish”aggressive and is associated with autosomal dominant
variant (APPswe) is endoproteolytically cleaved at theinheritance of mutations in genes encoding the amyloid
lumenally exposed “b-secretase” site in the Golgi com-precursor protein (APP) (for review, see Busfield and
partment, resulting in the production of a distinct z12Goate, 1995), presenilin 1 (PS1) (Sherrington et al., 1995),
kDa fragment of 99 amino acids extending from Asp-1and presenilin 2 (PS2) (Levy-Lahad et al., 1995a, 1995b;
of the Ab peptide to the extreme C-terminus of APPRogaev et al., 1995). Mutations in PS1 account for up
(Thinakaran et al., 1996b). Taking advantage of this find-to 50% of early-onset familial Alzheimer’s disease (FAD)
ing, we designed a strategy aimed at testing whethercases (Schellenberg, 1995). To date, over 30 missense
potential TM helices of PS1 were sufficient to exportmutations (for review, see Van Broeckhoven, 1995) and
APP sequences that included the Swedish mutationsa point mutation upstream of a splice acceptor site re-
into the Golgi lumen. We generated cDNA encoding asulting in an inframe deletion of exon 9 (PS1DE9) (Perez-
chimeric protein (TM1–APP) consisting of a 132 aminoTur et al., 1995) have been identified in the PS1 gene in
acid region of PS1 representing the N-terminal 80 aminofamilies with early-onset FAD. The normal function(s) of
acids, first predicted TM, and 31 amino acids down-
stream fused to a 167 amino acid region of APP that
includes 96 amino acids of the ectodomain harboring7 These authors contributed equally to this work.
Neuron
1024
Figure 1. Localization of PS1 N-Terminus
(A) Schematic representation of PS1–APP
chimeras. TM1–APP (TM1) consists of N-ter-
minal 132 residues of huPS1 (includes the
first TM), fused to C-terminal 167 residues of
huAPP-695swe. TM2–APP (TM2) is similar to
TM1–APP but consists of N-terminal 163 resi-
dues of PS1 (includes the first and second
TM domains). Light grey bar denotes PS1 TM
domains marked TM1 and TM2; solid black
box denotes APP TM domain; open bar de-
notes PS1 residues; dark grey bar denotes
APP residues. APP Swedish mutations are
denoted by NL.
(B) Metabolism of PS1–APP chimeric poly-
peptides. COS-1 cells transfected with plas-
mids encoding chimeric polypeptides were
labeled for 3 hr with [35S]methionine. Lanes
1–6 represent C-terminal APP fragments (a
and b CTF) immunoprecipated from cell
lysates with Ab369 antiserum. Lanes 1’-6’
represent Ab immunoprecipitated from con-
ditioned medium using monoclonal anti-
body 4G8.
(C) Indirect IF staining of PS1–APP chimeric
polypeptides. Transfected COS-1 cells were
incubated with Ab369 to visualize chimeric
PS1–APP (red) and DAPI to visualize nuclei
(blue).
(D) Schematic representation of membrane
topology of chimeric PS1–APP polypep-
tides. Double arrowheads represent a- and
b-secretase cleavage sites.
the Swedish double mutation, the TM, and C-terminal of TM1–APP. We anticipated that introduction of the
APP SS in ssTM1–APP would force translocation of thedomains (Figure 1A). This chimera could adopt two con-
figurations wherein the PS1 N-terminal domain is resi- PS1 region into the lumen of the ER/Golgi. Two potential
topologies could be envisioned for the ssTM1–APP chi-dent either in the cytoplasm or in the ER/Golgi lumen;
b-secretase cleavage of the chimera would only occur mera: the entire PS1 region (including TM1) is lumenal;
or,only theN-terminal 80 aminoacids of PS1are lumenalif the PS1 N-terminus is cytoplasmic. We transiently
expressed TM1–APP in COS-1 cells and demonstrated and TM1 is membrane inserted (see Figure 1D, ssTM1).
In the latter case, the APP b-secretase cleavage sitethe accumulation of an z12 kDa C-terminal fragment
(CTF) in cell lysates (Figure 1B, lane 3) that comigrates would now be located in the cytosolic compartment
where b-secretase is inactive (or absent). COS-1 cellswith an authentic b-secretase-generated derivative in
cells expressing native APPswe (Figure 1B, lane 1). In expressing ssTM1–APP neither generated CTF (Figure
1B, lane 4), nor released Ab (Figure 1B, lane 4’), despiteaddition, we observed intracellular accumulation of an
z10 kDa CTF generated by “a-secretase” (Figure 1B, the demonstration that the chimera had reached the
Golgi, a site for b-secretase cleavage of APPswe (Figurelane 3) and the presence of Ab in the medium of cells
expressing TM1–APP (Figure 1B, lane 3’), findings simi- 1C, ssTM1). Failure to detect APP CTF in cells express-
ing ssTM1–APP supports our view that both the PS1lar to cells expressing APPswe (Figure 1B, lane 1 and
lane 1’, respectively). These data support the idea that and APP TMs span the bilayer (as shown in Figure 1D,
ssTM1) and argue against the alternative model in whichTM1–APP adopts a configuration that orients the PS1
N-terminus toward the cytoplasm (see Figure 1D, TM1). the entire PS1 segment is lumenal. Hence, these data
support the view that the PS1 N-terminus is exposed toHowever, cleavage at the b-secretase site could also
occur if the PS1 N-terminus is lumenal and TM1 does the cytoplasm.
We extended this strategy to examine TM2–APP, anot span the bilayer. In this case, only the APP TM
domain would anchor the chimera in the membrane. To chimera composed of the N-terminal 163 amino acids
of PS1 that included the first two predicted TM domainscontrol for the possibility that TM1–APP might adopt an
alternative configuration that orients the PS1N-terminus of PS1 fused to the identical region of APPswe used in
the TM1–APP chimera. If our conclusions regarding thetoward the ER/Golgi lumen, we examined the pro-
cessing of ssTM1–APP, a chimera containing the APP topology of TM1–APPare correct, then TM2–APP should
also adopt a configuration that orients the N-terminussignal sequence (SS) fused to the extreme N-terminus
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Figure 2. Demonstration That Cytoplasmic
Epitopes Are Preferentially Recognized by
Specific Antibodies in SLO-Permeabilized
CHO-695 Cells
CHO-695 cells stably expressing huAPP were
transiently transfected with huPS1, and ana-
lyzed via indirect IF after treatment with either
SLO (A, B, E, and F) or Triton X-100 (C, D, G,
and H). All cells were incubated with DAPI to
visualize nuclei (blue) before coverslipping.
(A) and (B) Cells coincubated with the PS1
N-terminus antibody, Ab14 (red), and an anti-
body specific for APP lumenal epitopes, mAb
P2-1 (green) after SLO permeabilization.
(C) and (D) Cells coincubated with Ab14 (red)
and mAb P2-1 (green) after Triton permeabili-
zation. Arrowhead indicates a transfected cell
expressing huPS1.
(E) and (F) Cells coincubated with an antibody specific for APP cytosolic epitopes, Ab369 (red), and the ER lumenal protein Grp78, BiP (green)
following SLO permeabilization.
(G) and (H) Cells coincubated with Ab369 (red) and BiP (green) after permeabilization with Triton.
toward the cytoplasm (see Figure 1D, TM2). In this con- indirect immunofluorescence (IF) microscopy. The mAb
figuration, the protease-sensitive site is cytoplasmic, P2-1 served to control for inadvertent permeabilization
thus rendering the TM2–APP chimera incompetent for of IMs by SLO. As expected, Ab14 detected PS1
b-secretase cleavage. As expected,we neither detected N-terminal epitopes (Figure 2A) in SLO-treated cells,
APP CTF in cell lysates, nor Ab in the medium of COS-1 while mAb P2-1 binding to APP was undetectable (Fig-
cells expressing TM2–APP (Figure 1B, lane 5 and lane ure 2B). These studies confirmed that IMs were resistant
5’, respectively), despite transport of the chimera to the to permeabilization by SLO. On the other hand, cells
Golgi (Figure 1C, TM2). On the other hand, ssTM2–APP, permeabilized with Triton X-100 and incubated with anti-
a chimera containing the APP SS juxtaposed to the bodies Ab14 and mAb P2-1 bound cognate epitopes as
N-terminus of TM2–APP, was efficiently processed by expected (Figures 2C and 2D, respectively). Our demon-
b-secretase to generate an z12 kDa C-terminal deriva- stration that Ab14 bound PS1 in SLO-permeabilized
tive (Figure 1B, lane 6). Thus, the ssTM2–APP chimera cells in the absence of detectable disruption of IMs
must have adopted a configuration that orients the PS1 supports our earlier conclusion from analysis of PS1–
N-terminus toward the lumen (see Figure 1D, ssTM2). APPswe chimeras that the PS1 N-terminus is located
These studies indicate that the predicted TM1 and TM2 on the cytoplasmic face of IMs.
helices of PS1 span the bilayer. Moreover, efficient We performed additional control experiments to con-
b-secretase cleavage of the ssTM2–APP chimera con- firm that our failure to detect APP with mAb P2-1 in
firms our earlier conclusion that the N-terminus of PS1 SLO-permeabilized cells is not an artifact of the permea-
is oriented toward the cytoplasm. bilization procedure, per se. We coincubated CHO-695
cells with a rabbit polyclonal antibody, Ab369, that rec-
Confirmation of the Cytoplasmic Orientation ognizes epitopes in the APP cytoplasmic domain (Bux-
of the PS1 N-Terminus baum et al., 1990) and a mAb specific for a lumenally
To confirm directly the cytoplasmic localization of the disposed epitope (KSEKDEL) of the ER chaperone
N-terminus of native huPS1, we developed a strategy Grp78 (BiP) (Huovila et al., 1992). As expected, Ab369
in which the plasma membrane (PM) of cultured cells bound APP C-terminal epitopes in both SLO- (Figure
was selectively permeabilized with the pore-forming 2E) and Triton-permeabilized cells (Figure 2G); on the
bacterial toxin streptolysin-O (SLO). Subsequently, we other hand, BiP staining was only observed in Triton-
asked whether antibodies raised against PS1 N-terminal treated cells (Figure 2H). Collectively, these results dem-
peptides could bind cognate sequences associated with onstrate that SLO selectively permeabilizes the PM and
intracellular membranes (IMs). SLO binds selectively to that this approach allows access of specific antibod-
cholesterol (found predominantly on the PM), resulting ies to cognate epitopes located on the cytosolic face
in the formation of pores exceeding 30 nm on the PM of IMs.
without affecting IMs (Bhakdi et al., 1993). For our stud-
ies, huPS1 cDNA was transiently transfected into a sta-
The PS1 Loop and C-Terminal Regions Areble CHO line expressing huAPP-695 (CHO-695) (Sisodia
Oriented toward the Cytoplasmet al., 1993). HuPS1 was detected with Ab14, a poly-
Using the SLO permeabilization protocol describedclonal antiserum specific for amino acids 3–15 (Thina-
above, we sought to determine the orientation of thekaran et al., 1996a). Transfected cell monolayers were
PS1 loop and C-terminus. For these studies, we usedpermeabilized with SLO, or Triton X-100, then fixed prior
aPS1Loop, a polyclonal antibody specific for epitopesto antibody incubation. SLO- or Triton-treated cells were
between amino acids 320–390 in the PS1 loop regioncoincubated with PS1 N-terminal antibody, Ab14, and
(Thinakaran et al., 1996a) and Ab4627, a polyclonal anti-a monoclonal antibody (mAb), P2-1, specific for N-termi-
body specific for C-terminal amino acids 457–467 ofnal lumenally disposed epitopes of huAPP (Van Nos-
trand et al., 1989). Bound antibodies were detected by PS1 (Citron et al., 1996, Neurobiol. Aging, abstract). As
Neuron
1026
Figure 3. Cytoplasmic Localization of the
PS1 Loop and C-Terminal Domains in CHO-
695 Cells
CHO-695 were transfected and analyzed by
indirect IF microscopy as described in the
legend of Figure 2.
(A) and (B) Cells coincubated with aPS1Loop
(red) and an antibody specific for APP lume-
nal epitopes, mAb P2-1 (green), following
SLO permeabilization.
(C) and (D) Cells coincubated with aPS1Loop
(red) and mAb P2-1 (green) subsequent to
permeabilization with Triton.
(E) and (F) Cells coincubated with antibodies
specific to PS1 C-terminal epitopes Ab4627
(red) and mAb P2-1 (green) after permeabili-
zation with SLO.
(G) and (H) Cells coincubated with Ab4627
(red) and mAb P2-1 (green) after Triton per-
meabilization.
before, CHO-695 cells transiently expressing huPS1 Analysis of a FAD-Linked PS1 Variant
Lacking Exon 9 (PS1DE9)were permeabilized with either SLO or Triton, then coin-
cubated with a combination of aPS1Loop and APP- In an earlier report, we provided a secondary structure
prediction for PS1 that proposed the presence of ninespecific mAb P2-1. Similar to our findings with the PS1
N-terminal antibody, Ab14 (Figure 2A), the aPS1Loop TMs (Slunt et al., 1995), which differed from the seven
TM model proposed by Sherrington et al. (1995) by theantibody detected PS1 epitopes in SLO-treated cells
(Figure 3A), conditions that limited access of mAb P2-1 inclusion of potential TMs between residues 280–300
(within the PS1 loop domain) and 431–457 in the C-ter-to APP (Figure 3B). This result confirms that the PS1
loop is exposed to the cytoplasm. Parallel analysis of minus. In view of our demonstration that the N-terminal
and loop domains of PS1 are localized in the cytosolicSLO-treated cells using Ab4627 revealed that the PS1
C-terminus is also exposed to the cytoplasm (Figure face of IMs, it seemed reasonable that the first six pre-
dicted TMs be used. However, the presence of a seventh3E). Collectively, these studies confirm that the loop
and C-terminal domains of PS1 are oriented toward the putative TM, which spanned amino acids 280–300,
posed a conundrum; if used, the loop would have to becytoplasmic face of IMs.
lumenally disposed, a model that would disagree with
the conclusions drawn from our SLO permeabilizationTopology Studies in Stable N2a Cells
and antibody tagging studies. To address this issue, weWhile our conclusions from the colocalization studies in
analyzed the topology of PS1DE9, an FAD-linked PS1CHO-695 cellsappeared internally consistent, we feared
variant that lacks exon 9 (amino acids 290–319) and failsthat transient high level expression of PS1 may lead to
to undergo endoproteolytic cleavage (Thinakaran et al.,spurious folding of the polytopic protein into a structure
1996a). This deletion mutation removes the C-terminalthat is not physiologic. To overcome this uncertainty,
10 amino acids of the putative seventh TM (amino acidswe chose to repeat the entire series of experiments,
290–300). Hence, we anticipated that the residual 10described above, in a mouse neuroblastoma cell (N2a)
amino acids of the putative helix would be unable tothat stably coexpresses huPS1 and huAPP (line N2-
transverse the lipid bilayer, resulting in reversal of theawt.25, Borchelt et al., 1996). In this case, the cells are
orientation of the loop domain; deletion of a TM in aclonally derived and hence staining of huAPP or huPS1
multi-TM protein is known to reverse orientation of theis expected to be uniform between individual cells. Simi-
downstream region of the polypeptide (McGovern et al.,lar to our observations in CHO-695 cells transiently ex-
1991; Hollman et al., 1994). To examine the topology ofpressing PS1, we document that Ab14 detects PS1
PS1DE9 variant, we transiently expressed PS1DE9 inN-terminal epitopes on the cytoplasmic face of IMs in
SLO-permeabilized N2a cells (Figure 4A) under condi- CHO-695 cells and demonstrated cytosolic staining with
aPS1Loop antibody (Figure 5A) under conditions thattions that do not disrupt ER/Golgi membranes (Figure
4B). Furthermore, we demonstrate that both the aPS1- failed to reveal lumenal APP epitopes (Figure 5B). More-
over, the aPS1Loop antibody only detected cytosol-Loop and Ab4627 antibodies, specific for the PS1 loop
and C-terminal domains, respectively,detected cytosol- ically disposed epitopes of PS1DE9 in a N2a cell line
stably expressing PS1DE9 and huAPP (Figure 5E; lineically disposed epitopes in SLO-treated cells (Figures
4E and 4I, respectively), under conditions in which mAb N2aPS1DE9.18, Borchelt et al., 1996). These studies
confirm that the orientation of the PS1 loop in theP2-1 failed to bind lumenal APP epitopes (Figures 4B,
4F, 4J, and 4N). Additionally, surface staining of PS1 PS1DE9 variant is cytoplasmic, and hence, we argue
that it is highly unlikely that amino acids 280–300 spanwith Ab14, aPS1Loop, and Ab4627 was not detectable
in intact cells, confirming that PS1 is predominantly resi- the lipid bilayer. Nevertheless, it is conceivable that the
hydrophobic sequence of TM7 is associated with, ordent in IMs (data not shown). In the aggregate, our stud-
ies in stable N2a cells confirm our analysis in transiently partially included within, the lipid bilayer, in a manner
similar to that suggested for a putative TM (TMD II)transfected CHO-695 cells and provide compelling sup-
port for a topological model that orients the N-terminus, of the subunits of AMPA glutamate receptors, GluR1
(Hollman et al., 1994) and the goldfish kainate bindingloop, and C-terminus of PS1 toward the cytoplasm.
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Figure 4. PS1 N-Terminus, Loop, and C-Ter-
minus Localization in N2a Cells Stably Ex-
pressing huPS1 and huAPP
N2a cells stably expressing both huPS1 and
APP were analyzed via indirect IF after treat-
ment with either SLO (A, B, E, F, I, J, M, and
N) or Triton X-100 (C, D, G, H, K, L, O, and P).
All cells were incubated with DAPI to visualize
nuclei (blue) before coverslipping.
Following SLO permeabilization, cells were
coincubated with Ab14 (red) and mAb P2-1
(green) (A and B), aPS1Loop (red) and mAb
P2-1 (green) (E and F), Ab4627 (red) and mAb
P2-1 (green) (I and J), or Ab369 (red) and
mAb P2-1 (green) (M and N).
Subsequent to Triton permeabilization, cells
were coincubated with Ab14 (red) and mAb
P2-1 (green) (C and D), aPS1Loop (red) and
mAb P2-1 (green) (G and H), Ab4627 (red) and
mAb P2-1 (green) (K and L), or Ab369 (red)
and mAb P2-1 (green) (O and P).
Live cells incubated with Ab14, aPS1Loop,
and Ab4627 fail to exhibit PS1 IF staining on
the cell surface, whereas, Triton-permeabil-
ized cells stained brightly with these antibod-
ies after 1 hr incubation (data not shown).
proteins (GFKARa and GVKARb) (Wo and Oswald, 1994), Greenwald, 1995). Moreover, and in view of our recent
description of the endoproteolytic cleavage of PS1 (Thi-and recently proven for the ionotropic NMDA receptor
channel M2 segment (Kuner et al., 1996). nakaran et al., 1996a), we sought to determine thedispo-
sition of the protease-sensitive region.
We determined the topology of the PS1 N-terminusDiscussion
using two novel strategies. First, we examined the me-
tabolism of chimeric molecules composed of the N-ter-The majority of FAD cases are linked to mutations in
highly homologous genes encoding multi-TM proteins, minal tail of PS1 and either one (TM1) or two (TM2)
putative TMs fused to a 167 amino acid C-terminal re-termed PS1 and PS2. We examined the topology of PS1
in order to define regions of the protein that may be gion of APP harboring FAD-linked Swedish substitu-
tions. We demonstrated that the TM1–APP chimera wasinvolved in binding cellular factors that transduce PS1-
specific functions. In this regard, a PS homolog in C. endoproteolytically cleaved by b-secretase, an activity
restricted to the lumen of the Golgi. Hence, we con-elegans, termed SEL-12, facilitates intracellular signal-
ing mediated by LIN-12/Notch activation (Levitan and cluded that the PS1 TM1–APP was sufficient to mediate
Figure 5. Loop Localization in Cells Express-
ing FAD-Linked Splice Variant PS1DE9
(A) and (B) CHO-695 cells transiently trans-
fected with huPS1DE9 were coincubatedwith
aPS1Loop (red) and mAb P2-1 (green) follow-
ing SLO permeabilization. DAPI was used to
visualize nuclei (blue) in these cells as well as
the other cells in this figure.
(C) and (D) CHO-695 cells transiently trans-
fected with huPS1DE9 werecoincubated with
aPS1Loop (red) and mAb P2-1 (green) after
Triton permeabilization.
(E) and (F) N2a cells stably transfected with
huPS1DE9 were coincubated with aPS1Loop
(red) and mAb P2-1 (green) after permeabili-
zation with SLO.
(G) and (H) N2a cells stably transfected with
huPS1DE9 were coincubated with aPS1Loop
(red) and mAb P2-1 (green) after Triton per-
meabilization.
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450. We offer these models, since we felt it unlikely
that the dilysine spacer serves as a “kink,” and hence
promote insertion of the last TM segment. However, it
is conceivable that all, or part, of this entire segment is
partially included within the bilayer. Figures 6C and 6D
offer the suggestion that the last two potential TMs span
the lipid bilayer. While experimental evidence to support
this notion is unavailable, we have demonstrated that
PS1 N- and C-terminal derivatives are integrally bound
to brain microsomal membranes under conditions that
strip membrane-associated molecules (D. R. B., G. T.,
S. S. S., unpublished data). Thus, one or both of the last
two predicted TMs appear to be inserted in the bilayer.
In summary, we employed two novel strategies to
examine PS1 topology and have reached the conclusion
that PS1 is a multi-TM protein with the N-terminus, loop,
and C-terminal domains oriented toward the cytosolic
face of intracellular membranes. In view of the highFigure 6. PS1 Topology Derived from TM1/2–APP Chimera Analysis
structural homology between PS1 and PS2, we predictand Selective Permeabilization and Antibody Tagging Studies
that the homologs have similar topologies. We, and oth-Dark grey filled ovals denote putative TM of PS1; light grey filled oval
denotes the putative seventh TM (amino acids 280–300). Proposed ers (Lee et al., 1996; Rogaev et al., 1995; Kovacs et al.,
cleavage site for PS1 is indicated by arrowhead. 1996), have demonstrated that PS1 and PS2 mRNAs are
ubiquitously expressed in a variety of tissues during
development and in aging. Taken together with the
translocation of the b-secretase site to the lumen, a structural conservation, these data suggest some de-
finding that led to the conclusion that the PS1 N-termi- gree of functional redundancy. However, the cytosolic
nus is oriented toward the cytoplasm. domains of the two homologs are highly divergent
To confirm that the N-terminus of PS1 is oriented (<10% identity in the N-terminal 70 amino acids and
toward the cytoplasm, we used a bacterial pore-forming between amino acids 305–375, in the loop), suggesting
toxin, SLO, to permeabilize selectively the plasma mem- that these regions mediate cell- or PS-specific functions
brane of mammalian cells that transiently or stably ex- via differential interaction(s) with proteins in the cyto-
press wild-type PS1. Perforatedcells weresubsequently plasm. Future efforts aimed at the identification and
incubated with PS1-specific N-terminal antibodies. Indi- characterization of molecules that interact with PS-spe-
rect IF microscopy revealed that the antibody bound cific cytosolic domains are critical for the elucidation
cytosolic epitopes; failure of antibodiesspecific to lume- of the biological function(s) of this novel class of TM
nal epitopes of APP or Grp78 to detect cognate epitopes proteins.
in SLO-permeabilized cells confirmed that the permea-
bilization procedure did not disrupt ER/Golgi mem- Experimental Procedures
branes. Taken together with the data obtained by analy-
Generation of Expression Vectors Encodingsis of the PS1–APP chimeras, we conclude that the
PS1–APP Chimeric ProteinsN-terminus of PS1 is cytosolic. We exploited the SLO
Sequences encoding the N-terminal 132 amino acids of huPS1 were
permeabilization strategy to investigate the disposition amplified by PCR using pBSHuPS1 (Slunt et al., 1995) as template
of the PS1 loop and C-terminal domains, using epitope- and primers 59 CCAGATCTGGAAGGAACCTGAGC 39 (FHuPS1) and
specific antibodies, and confirmed that the loop and 59 GCTTGAGCTCTGAGTGCAGGGCTCTCTGG 39. Sequences en-
coding the N-terminal 163 amino acids were amplified using theC-terminal domain of PS1 are oriented toward the cyto-
sense primer FHuPS1 (above) and antisense primer, 59GCTTGAGCTplasm. Collectively, these data support a model that
CATGGATGACCTTATAGCACC 39. The PCR products were digestedorients the PS1 N-terminus, loop, and C-terminus to-
with BglII and XbaI, gel purified, and incubated in a ligation reaction
ward the cytoplasm. containing a gel-purified SstI–XbaI fragment from plasmid pAPP-
Consistent with these conclusions, we now propose 695swe (Lo et al., 1994) and pCB6 vector (Lo et al., 1994) with BglII
four topology models for PS1 (see Figure 6). Each of and XbaI ends. The resulting plasmids encode chimeric proteins
containing the N-terminus and predicted first TM of PS1 (pCB6TM1),the models assumes that the first six putative TM helices
or the first two TMs of PS1 (pCB6TM2), fused to the C-terminalare used. Our assumption is based on thehigh homology
167 amino acids of APP containing the Swedish double mutation.of these domains between PS1, PS2, and SEL-12, and
Sequences encoding the signal peptide of huAPP were isolated as
the demonstration that the first six TMs of SEL-12 are a 105 bp BamHI–Asp-718 fragment from plasmid p770 (Sisodia et
utilized (Li and Greenwald, 1996). A unique feature of al., 1990), and the ends were filled in, using Klenow fragment of
the topology models (Figures 6A–6D) is the presence of DNA polymerase. This fragment was ligated to plasmids pCB6TM1
and pCB6TM2 previously digested with Asp-718 and the ends filleda predicted TM near the N-terminus of the loop domain,
to generate pCB6ssTM1 or pCB6ssTM2, respectively.which may (Figures 6B and 6D) or may not (Figures 6A
and 6C) be associated with (but in neither case trans-
Metabolism of PS1–APP Chimeric Proteinsverses) the lipid bilayer; in either case, the loop is ori-
COS-1 cells were transfected with plasmids encoding PS1–APP
ented toward the cytosolic face. Also shown in Figures chimeric proteins using a CaPO4 coprecipitation procedure (Chen
6A and 6B is the bilayer association of two predicted and Okayama, 1987). At 36 hr after transfection, cells were labeled
with 250 mCi/ml [35S]methionine for 3 hr. Cell-associated C-terminalmembrane-spanning helices between amino acids 408–
PS1 Topology
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APP derivatives were immunoprecipitated from detergent lysates are the recipients of a Leadership and Excellence in Alzheimer’s
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